Rik Schots

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

Jesús F. San Miguel, Rudolf Schlag, Nuriet K. Khuageva et al. · New England Journal of Medicine · 2008 · 1.9K citations · Full text

High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Thierry Philip, Jamés O. Armitage, Gary Spitzer et al. · New England Journal of Medicine · 1987 · 780 citations

Cell Therapy, Refractory Group, Pathology +18

Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial

María‐Victoria Mateos, Paul G. Richardson, Rudolf Schlag et al. · Journal of Clinical Oncology · 2010 · 431 citations · Full text

Comparison of CHOP Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-Hodgkin's Lymphoma

Leo F. Verdonck, Wim L.J. van Putten, Anton Hagenbeek et al. · New England Journal of Medicine · 1995 · 280 citations · Full text

VMP (Bortezomib, Melphalan, and Prednisone) Is Active and Well Tolerated in Newly Diagnosed Patients With Multiple Myeloma With Moderately Impaired Renal Function, and Results in Reversal of Renal Impairment: Cohort Analysis of the Phase III VISTA Study

Meletios Α. Dimopoulos, Paul G. Richardson, Rudolf Schlag et al. · Journal of Clinical Oncology · 2009 · 171 citations · Full text